Axonics to Participate in November Investor Conferences
November 01 2023 - 6:00AM
Business Wire
Axonics, Inc. (Nasdaq: AXNX), a global medical technology
company that is developing and commercializing novel products for
the treatment of bladder and bowel dysfunction, is scheduled to
participate in the following investor conferences in November:
Event: Wolfe Research Healthcare Conference Date: Tuesday,
November 14 Presentation time: 12:30 p.m. Eastern Time
Event: Piper Sandler Healthcare Conference Date: Wednesday,
November 29 Presentation time: 10:30 a.m. Eastern Time
Interested parties may access a live webcast and replay of each
presentation by visiting the Axonics investor relations
website.
About Axonics
Axonics is a global medical technology company that is
developing and commercializing novel products for adults with
bladder and bowel dysfunction. Axonics recently ranked No. 2 on the
2023 Financial Times ranking of the fastest growing companies in
the Americas and No. 4 on the 2022 Deloitte Technology Fast
500.
Axonics® sacral neuromodulation systems provide adults with
overactive bladder and/or fecal incontinence with long-lived, easy
to use, safe, clinically effective therapy. In addition, the
company’s best-in-class urethral bulking hydrogel, Bulkamid®,
provides safe and durable symptom relief to women with stress
urinary incontinence. In the U.S., moderate to severe urinary
incontinence affects an estimated 28 million women and fecal
incontinence affects an estimated 19 million adults. For more
information, visit www.axonics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231101221067/en/
Axonics contact: Neil Bhalodkar 949-336-5293
IR@axonics.com
Axonics (NASDAQ:AXNX)
Historical Stock Chart
From Apr 2024 to May 2024
Axonics (NASDAQ:AXNX)
Historical Stock Chart
From May 2023 to May 2024